Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of concept.
Resveratrol provides multiple physiologic benefits which promote healthspan in various model species and clinical trials support continued exploration of resveratrol treatment in humans. However, there remains concern regarding low bioavailability and wide inter-individual differences in absorption...
Saved in:
| Main Authors: | Otis L Blanchard, Gregory Friesenhahn, Martin A Javors, James M Smoliga |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090131&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transmucosal Delivery of miR-30c-5p by Chitosan Nanoparticles for Oral Squamous Cell Carcinoma
by: Fang YP, et al.
Published: (2025-07-01) -
Sprays and lozenges for sore throats
by: F. Farrer
Published: (2012-04-01) -
RANGE AND CHARACTERISTICS TRANSMUCOSAL DOSAGE FORMS
by: N. V. Shestakov, et al.
Published: (2019-01-01) -
The pharmacokinetics of hexylresorcinol-containing lozenges and their antimicrobial efficacy against oral and respiratory microorganisms
by: Priyanka Sharma, et al.
Published: (2025-12-01) -
Oral transmucosal fentanyl citrate as breakthrough pain relieving medication: A pilot study
by: Naresh Dua, et al.
Published: (2024-08-01)